Heidi Turns Its AI Toward the Language Barrier

Forty-five percent of Monash Health's patients speak a language other than English at home. That figure is not unusual in Australia's major cities. What is unusual is that a clinical AI company has decided to treat it as a product problem

Heidi Health and Monash Health have partnered to co-develop and evaluate a real-time language translation system designed to support communication between patients, families, and clinicians during consultations and inpatient care. The trial launched in early June 2026 across Monash Health's hospitals and clinics, initially covering 10 commonly spoken languages. The system is being evaluated in live clinical settings, meeting hospital standards for privacy, security, and clinical safety rather than laboratory conditions

Professional interpreters will continue to be used for complex or sensitive conversations. The trial is designed to establish where AI translation can support everyday communication without replacing those services, a distinction that matters both ethically and practically. Deploying inside a large public health service subjects Heidi's software to standards more demanding than most private-sector environments could impose

The product launch reflects a broader strategic shift. In February 2026, Heidi released two major additions: Heidi Evidence, a clinical decision support tool built with HealthPathways, BMJ Group, and NICE, and Heidi Comms, a patient communications platform. Translation, documentation, evidence access, patient outreach: the company is building what amounts to an operating system for primary and community care. Whether that ambition survives contact with the complexity of real clinical environments will take more than one trial to determine